The inflammatory tissue microenvironment in IBD

Inflamm Bowel Dis. 2013 Sep;19(10):2238-44. doi: 10.1097/MIB.0b013e31828dcaaf.


A current view of the inflammatory bowel diseases (IBDs) includes the luminal triggering of innate immune disease in a genetically susceptible host. Given the unique anatomy and complex environment of the intestine, local microenvironmental cues likely contribute significantly to both disease progression and resolution in IBD. Compartmentalized tissue and microbe populations within the intestine result in significant metabolic shifts within these tissue microenvironments. During active inflammatory disease, metabolic demands often exceed supply, resulting in localized areas of metabolic stress and diminished oxygen delivery (hypoxia). There is much recent interest in harnessing these microenvironmental changes to the benefit of the tissue, including targeting these pathways for therapy of IBD. Here, we review the current understanding of metabolic microenvironments within the intestine in IBD, with discussion of the advantages and disadvantages of targeting these pathways to treat patients with IBD.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Cellular Microenvironment / immunology*
  • Humans
  • Inflammation / etiology*
  • Inflammatory Bowel Diseases / complications
  • Inflammatory Bowel Diseases / immunology*
  • Intestinal Mucosa / immunology*
  • Prognosis